Menu
Back to Journals » Drug Design, Development and Therapy » Volume 15
Cinobufagin Suppresses the Characteristics of Osteosarcoma Cancer Cells by Inhibiting the IL-6-OPN-STAT3 Pathway [Retraction]
Received 21 October 2021
Accepted for publication 21 October 2021
Published 27 October 2021 Volume 2021:15 Pages 4445—4446
Zhang C, Ma K, Li WY. Drug Des Devel Ther. 2019;13:4075–4090.
The Editor and Publisher of Drug Design, Development and Therapy wish to retract the published article. The authors advised that errors were made in Figure 3A and they could not provide satisfactory original data that would validate the findings of their study. The Editor advised for the article to be retracted.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.